open access

Vol 19, No 4 (2015)
CASE REPORT
Published online: 2015-11-18
Get Citation

Hypertension management in acute kidney injury

Marta Sołtysiak, Krystyna Widecka
DOI: 10.5603/AH.2015.0026
·
Arterial Hypertension 2015;19(4):203-206.

open access

Vol 19, No 4 (2015)
CASE REPORT
Published online: 2015-11-18

Abstract

Despite the fact that in recent years the concept of hypertension treatment has been verified and the management in special situations and groups of patients has been standardized , there are not many reports of antihypertensive therapy in patients with acute kidney injury. Acute renal failure, defined as a sudden decline of kidney function, is a clinical syndrome of various etiologies, often accompanies by hypertension, and specific pathological mechanism determines the therapeutic management. Diuretics are first-line drugs, particularly preferred in patients with volume overload. RAA blockers are not recommended for the hypertension treatment in acute kidney injury, but the broad definition of AKI forces individualization of therapy in various clinical situations - the results of large clinical trials show the benefits of ACE inhibitors in cases of HTA associated with acute glomerulopathies or vasculitis. Prevalence of drugs that affect potassium levels contribute to the rising incidence of hyperkalemia, which can be a consequence of both — acute and chronic kidney diseases. In case of a dynamically growing levels of potassium in AKI there is a need to decrease the dose or withdrawal of RAA blockers and mineralocorticoid antagonists.

Abstract

Despite the fact that in recent years the concept of hypertension treatment has been verified and the management in special situations and groups of patients has been standardized , there are not many reports of antihypertensive therapy in patients with acute kidney injury. Acute renal failure, defined as a sudden decline of kidney function, is a clinical syndrome of various etiologies, often accompanies by hypertension, and specific pathological mechanism determines the therapeutic management. Diuretics are first-line drugs, particularly preferred in patients with volume overload. RAA blockers are not recommended for the hypertension treatment in acute kidney injury, but the broad definition of AKI forces individualization of therapy in various clinical situations - the results of large clinical trials show the benefits of ACE inhibitors in cases of HTA associated with acute glomerulopathies or vasculitis. Prevalence of drugs that affect potassium levels contribute to the rising incidence of hyperkalemia, which can be a consequence of both — acute and chronic kidney diseases. In case of a dynamically growing levels of potassium in AKI there is a need to decrease the dose or withdrawal of RAA blockers and mineralocorticoid antagonists.

Get Citation

Keywords

AKI, acute renal failure, hypertension

About this article
Title

Hypertension management in acute kidney injury

Journal

Arterial Hypertension

Issue

Vol 19, No 4 (2015)

Pages

203-206

Published online

2015-11-18

DOI

10.5603/AH.2015.0026

Bibliographic record

Arterial Hypertension 2015;19(4):203-206.

Keywords

AKI
acute renal failure
hypertension

Authors

Marta Sołtysiak
Krystyna Widecka

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl